|

Cabergoline Clinical Trials

1 actively recruiting trial

Pipeline

Phase 3: 1

Top Sponsors

  • University of Sao Paulo General Hospital1

Indications

  • Prolactin Excess1
  • Prolactinoma1
  • Cancer1

Other1 trial

Safety and Potency of a High Cabergoline Dosage in Microprolactinomas
Phase 3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.